Delivery of oligonucleotides: efficiency with lipid conjugation and clinical outcome
Oligonucleotides have shifted drug discovery into a new paradigm due to their ability to
silence the genes and inhibit protein translation. Importantly, they can drug the un-druggable …
silence the genes and inhibit protein translation. Importantly, they can drug the un-druggable …
Lipid conjugated oligonucleotides: a useful strategy for delivery
M Raouane, D Desmaële, G Urbinati… - Bioconjugate …, 2012 - ACS Publications
Oligonucleotides, including antisense oligonucleotides and siRNA, are promising
therapeutic agents against a variety of diseases. Effective delivery of these molecules is …
therapeutic agents against a variety of diseases. Effective delivery of these molecules is …
Oligonucleotide delivery: a patent review (2010–2013)
Introduction: The use of aptamers, antisense technology and RNA interference has allowed
nucleic acids to be considered as promising alternatives to classical drugs. However …
nucleic acids to be considered as promising alternatives to classical drugs. However …
Double-tailed lipid modification as a promising candidate for oligonucleotide delivery in mammalian cells
B Ugarte-Uribe, S Grijalvo, JV Busto, C Martín… - … et Biophysica Acta (BBA …, 2013 - Elsevier
Background The potential use of nucleic acids as therapeutic drugs has triggered the quest
for oligonucleotide conjugates with enhanced cellular permeability. To this end, the …
for oligonucleotide conjugates with enhanced cellular permeability. To this end, the …
Lipid and peptide-oligonucleotide conjugates for therapeutic purposes: from simple hybrids to complex multifunctional assemblies
Antisense and small interfering RNA (siRNA) oligonucleotides have been recognized as
powerful therapeutic compounds for targeting mRNAs and inducing their degradation …
powerful therapeutic compounds for targeting mRNAs and inducing their degradation …
Recent preclinical and clinical advances in oligonucleotide conjugates
K Craig, M Abrams, M Amiji - Expert opinion on drug delivery, 2018 - Taylor & Francis
Introduction: Oligonucleotide therapeutics have the potential to change the way disease is
treated due to their ability to modulate gene expression of any therapeutic target in a highly …
treated due to their ability to modulate gene expression of any therapeutic target in a highly …
Delivery of oligonucleotides with lipid nanoparticles
Since their inception in the 1980s, oligonucleotide-based (ON-based) therapeutics have
been recognized as powerful tools that can treat a broad spectrum of diseases. The …
been recognized as powerful tools that can treat a broad spectrum of diseases. The …
Lipid and polymeric carrier-mediated nucleic acid delivery
Importance of the field: Nucleic acids such as plasmid DNA, antisense oligonucleotide, and
RNA interference (RNAi) molecules, have a great potential to be used as therapeutics for the …
RNA interference (RNAi) molecules, have a great potential to be used as therapeutics for the …
Lipid‐based nucleic acid therapeutics with in vivo efficacy
Synthetic vectors for therapeutic nucleic acid delivery are currently competing significantly
with their viral counter parts due to their reduced immunogenicity, large payload capacity …
with their viral counter parts due to their reduced immunogenicity, large payload capacity …
Evolution of complexity in non-viral oligonucleotide delivery systems: from gymnotic delivery through bioconjugates to biomimetic nanoparticles
K Bakowski, S Vogel - RNA biology, 2022 - Taylor & Francis
From the early days of research on RNA biology and biochemistry, there was an interest to
utilize this knowledge and RNA itself for therapeutic applications. Today, we have a series of …
utilize this knowledge and RNA itself for therapeutic applications. Today, we have a series of …
相关搜索
- delivery of oligonucleotides lipid conjugation
- delivery of oligonucleotides clinical outcome
- lipid conjugation clinical outcome
- mammalian cells oligonucleotide delivery
- promising candidate oligonucleotide delivery
- lipid modification oligonucleotide delivery
- delivery of oligonucleotides lipid nanoparticles